Instruction for use: Xymelin

Active substance: Xylometazoline

ATX Code R01AA07 Xylometazoline

Pharmacotherapeutic group:

Decongestants [alpha agonists]

Decongestants [decongestant]

The nosological classification (ICD-10)

H66 Suppurative and unspecified otitis media

Bacterial ear infections, Inflammation of the middle ear, Infections of the upper respiratory tract, Infectious-inflammatory diseases of ENT organs, Infectious-inflammatory diseases of upper respiratory tract, Infectious-inflammatory diseases of the ear, Infectious diseases of ENT organs with marked pain syndrome, ear Infection, Otitis media infection, Persistent inflammation of the middle ear in children, Ear pain of otitis

J00 Acute nasopharyngitis [runny nose]

Viral rhinitis, Inflammation of the nasopharynx, Inflammatory diseases of the nose, purulent rhinitis, Nasal congestion, Nasal congestion with colds and flu, The difficulty of nasal breathing, The difficulty of nasal breathing for colds, Difficulty in nasal breathing, Difficulty in nasal breathing in colds, nasal, hypersecretion, cold, ARI with rhinitis phenomena, coryza, Acute rhinitis of various origins, Acute rhinitis with thick purulent mucous exudate, Acute nasopharyngitis, Swelling of the mucosa of the nasopharynx, Rhinitis, rhinorrhea, Infectious-inflammatory diseases of ENT organs, heavy cold, rhinopharyngitis, nasopharyngitis

J01 Acute sinusitis

Inflammation of the sinuses, Inflammatory diseases of the paranasal sinuses, Purulent inflammation of the paranasal sinuses, Infectious-inflammatory diseases of ENT organs, Infection of the sinuses, Combined sinusitis, Exacerbation of sinusitis, Acute inflammation of the paranasal sinuses, Acute bacterial sinusitis, Acute sinusitis in adults, Subacute sinusitis, acute Sinusitis, sinusitis

Composition

Nasal drops 1 ml

Xylometazoline hydrochloride 0.5 mg

1 mg

Excipients: sodium dihydrogen phosphate; dibasic sodium phosphate; disodium edetate; sodium chloride; benzalkonium chloride; purified water

flakonah- in 10 ml polyethylene; In the paper cartons 1 Dropper bottle.

Nasal Spray 1 ml

Xylometazoline hydrochloride 0.5 mg

1 mg

Excipients: sodium dihydrogen phosphate; dibasic sodium phosphate; disodium edetate; sodium chloride; benzalkonium chloride; purified water

in dark glass bottles with a metering device 10 or 15 ml.

The drug forms

Clear, colorless liquid.

pharmachologic effect

Mode of action - a vasoconstrictor, alpha adrenomimeticheskoe.

Clinical pharmacology

The action comes after a few minutes and lasts 10-12 hours.

Indications

Difficulty in nasal breathing (acute rhinitis, sinusitis), otitis media (to reduce swelling of the mucous nasopharynx).

Contraindications

Angle-closure glaucoma.

Pregnancy and breast-feeding

Application is possible.

Side effects

Medical rhinitis, mucosal irritation (swelling, hypersecretion); in rare cases - systemic reactions (heart rate, tremors, insomnia, etc.).

Xymelin Dosage and Administration

Intranasal, adults and children over 6 years - 2-3 drops or 1 dose spray for children 2 to 6 years - 1-2 drops or 1 dose spray into each nostril 1-3 times a day. Drops of 1 mg / ml - adults and children over 6 years, drops 0.5 mg / ml - Children from 2 to 6 years old, spray 1 mg / ml - adults and children over 6 years old, spray 0.5 mg / ml - children 2-6 years.

The drug is administered less than 7 days.

Do not use in children under 2 years of age without a doctor's prescription.

Overdose

Symptoms: CNS depression, tachycardia, hypertension, fever, irritability, circular collapse, coma, convulsions.

Treatment: the use of alpha-agonists blocking agents.

Precautionary measures

Not recommended for use in high doses and too often in patients with hypertension, heart failure or thyrotoxicosis; caution is required when used in patients who are receiving MAO inhibitors.

Storage conditions of Xymelin

In a dry, dark place, at a temperature of 15-25 ° C.

Keep out of the reach of children.
Shelf life of Xymelin

2 years.

Do not use beyond the expiration date printed on the package.